M gross proceeds raised from pre-existing investors, providing capital runway into 2027All nine investors that were offered ...
Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced that it has submitted a Biologics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback